Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 30, 1998 - Issue 4: Therapeutic Ue of Hallucinogens
Submit an article Journal homepage
590
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Dr. Leary's Concord Prison Experiment: A 34-Year Follow-up Study

Rick Doblin Kennedy School of Government, Harvard University
Pages 419-426 | Published online: 06 Sep 2011

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sarah C.E. Riley & Graham Blackman. (2008) Between Prohibitions: Patterns and Meanings of Magic Mushroom Use in the UK. Substance Use & Misuse 43:1, pages 55-71.
Read now

Articles from other publishers (15)

Pravesh Sharma, Quang Anh Nguyen, Sadie J Matthews, Erin Carpenter, Douglas B Mathews, Christi A Patten & Christopher J Hammond. (2023) Psilocybin history, action and reaction: A narrative clinical review. Journal of Psychopharmacology 37:9, pages 849-865.
Crossref
Daniel R. George, Ryan Hanson, Darryl Wilkinson & Albert Garcia-Romeu. (2021) Ancient Roots of Today’s Emerging Renaissance in Psychedelic Medicine. Culture, Medicine, and Psychiatry 46:4, pages 890-903.
Crossref
Logan Neitzke-Spruill. (2022) Psychedelics and Desistance From Crime: Lessons From the Concord Prison Experiment. Journal of Humanistic Psychology, pages 002216782211362.
Crossref
Seetal Dodd, Trevor R. Norman, Harris A. Eyre, Stephen M. Stahl, Arnie Phillips, André F. Carvalho & Michael Berk. (2022) Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. CNS Spectrums, pages 1-11.
Crossref
Chris Elcock. (2021) Psychedelic philanthropy: The nonprofit sector and Timothy Leary's 1960s psychedelic movement. Journal of the History of the Behavioral Sciences 58:1, pages 85-104.
Crossref
Henry Lowe, Ngeh Toyang, Blair Steele, Henkel Valentine, Justin Grant, Amza Ali, Wilfred Ngwa & Lorenzo Gordon. (2021) The Therapeutic Potential of Psilocybin. Molecules 26:10, pages 2948.
Crossref
Collin M. ReiffElon E. RichmanCharles B. NemeroffLinda L. CarpenterAlik S. WidgeCarolyn I. RodriguezNed H. KalinWilliam M. McDonald. (2021) Psychedelics and Psychedelic-Assisted Psychotherapy. FOCUS 19:1, pages 95-115.
Crossref
Collin M. ReiffElon E. RichmanCharles B. NemeroffLinda L. CarpenterAlik S. WidgeCarolyn I. RodriguezNed H. KalinWilliam M. McDonald. (2020) Psychedelics and Psychedelic-Assisted Psychotherapy. American Journal of Psychiatry 177:5, pages 391-410.
Crossref
Peter Eischens & William Leigh Atherton. (2018) Psychedelic therapy as a complementary treatment approach for alcohol use disorders. Journal of Psychedelic Studies 2:1, pages 36-44.
Crossref
Christian Sueur. (2018) État des lieux de la recherche sur les capacités thérapeutiques des « substances hallucinogènes » au 21 e  siècle. Psychotropes Vol. 23:3, pages 125-163.
Crossref
Peter S Hendricks, Michael Scott Crawford, Karen L Cropsey, Heith Copes, N Wiles Sweat, Zach Walsh & Gregory Pavela. (2017) The relationships of classic psychedelic use with criminal behavior in the United States adult population. Journal of Psychopharmacology 32:1, pages 37-48.
Crossref
Zach Walsh, Peter S Hendricks, Stephanie Smith, David S Kosson, Michelle S Thiessen, Philippe Lucas & Marc T Swogger. (2016) Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use. Journal of Psychopharmacology 30:7, pages 601-607.
Crossref
Vicka Rael CoreyVincent D. PisanoJohn H. Halpern. (2016) Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting. Journal of Nervous & Mental Disease 204:7, pages 519-523.
Crossref
Peter S Hendricks, C Brendan Clark, Matthew W Johnson, Kevin R Fontaine & Karen L Cropsey. (2014) Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Journal of Psychopharmacology 28:1, pages 62-66.
Crossref
Katarzyna Stebelska. (2013) Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol. Therapeutic Drug Monitoring 35:4, pages 420-442.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.